国际麻醉学与复苏杂志   2022, Issue (2): 0-0
    
幕上肿瘤切除术患者手术失血量相关危险因素分析:一项回顾性队列研究
王德祥, 闫翔, 董佳, 曾敏, 彭宇明1()
1.首都医科大学附属北京天坛医院
Risk factors of intraoperative blood loss in patients undergoing supratentorial tumor resections: a retrospective cohort study
 全文:
摘要:

目的 探究幕上肿瘤切除手术患者术中失血的相关危险因素。 方法 本研究为单中心回顾性队列研究,收集310例2018年7月至2019年6月择期行幕上肿瘤切除术患者的临床资料(最终纳入203例),根据术中出血量是否大于500 ml将患者分为两组,即出血量>500 ml组(42例)和出血量≤500 ml组(161例),分析两组患者术前基线信息、麻醉和手术相关变量、术中快速血栓弹力图(rapid thromboelastography, r‑TEG)、术后并发症、住院时间及住院费用等情况,采用Logistic回归分析术中出血量>500 ml的相关因素。 结果 出血量>500 ml组患者中脑膜瘤、世界卫生组织(World Health Organization, WHO)分级为Ⅰ、Ⅱ级、颅前窝占位、肿瘤侵及血管、肿瘤最大直径≥4 cm、肿瘤部分切除以及手术时间>240 min的占比均高于出血量≤500 ml组患者(P<0.05)。单因素Logistic回归分析发现上述变量与出血量>500 ml存在相关性(P<0.05)。进一步多因素Logistic回归分析发现肿瘤最大直径≥4 cm[比值比(odds ratio, OR)=4.21,95%CI 1.52~11.71]、脑膜瘤(OR=9.05,95%CI 3.67~22.30)和手术时间>240 min(OR=4.88,95%CI 1.92~12.42)是出血量>500 ml的独立危险因素(P<0.05)。与出血量≤500 ml组比较,出血量>500 ml组患者活化凝血时间(activated coagulation time, ACT)明显延长(P<0.05)。r‑TEG异常与出血量>500 ml存在相关性(OR=3.56,95%CI 1.38~9.17,P<0.05)。出血量>500 ml组苏醒延迟、肺部感染、深静脉血栓发生率及住院费用高于出血量≤500 ml组(P<0.05)。 结论 肿瘤体积较大(直径≥4 cm)、脑膜瘤切除术及手术时间>240 min是患者术中失血量显著增加的危险因素。

关键词: 脑肿瘤; 失血量; 风险预测因子
Abstract:

Objective To investigate the risk factors of intraoperative blood loss in patients undergoing supratentorial tumor resections. Methods This was a single‑center retrospective cohort study. Clinical data were collected from 310 patients who were scheduled for supratentorial tumor resection from July 2018 to June 2019 (203 cases were eventually enrolled). The patients were divided into two groups depending on whether the intraoperative blood loss was more than 500 ml: a blood loss >500 ml group (n=42) and a blood loss ≤500 ml group (n=161). Both groups were compared for baseline information before surgery, anesthetic and operative information, intraoperative rapid thromboelastography (r‑TEG), postoperative complications, the length and cost of hospitalization stay. The logistic regression analysis was performed to predict the related factors of blood loss >500 ml. Results Patients with blood loss >500 ml showed higher percentages of meningioma, World Health Organization (WHO) grade Ⅰ‒Ⅱ, anterior cranial fossa space‑occupying lesions, tumor invasion, maximum diameter tumor ≥4 cm, tumor partial resection and operation duration >240 min than those with blood loss ≤500 ml (P<0.05). Univariate logistic regression analysis showed that the above variables were correlated with blood loss >500 ml (P<0.05). Furthermore, multivariate logistic regression showed that the maximum diameter tumor ≥4 cm [odds ratio (OR)=4.21, 95%CI 1.52‒11.71], meningioma (OR=9.05, 95%CI 3.67‒22.30) and operation duration >240 min (OR=4.88, 95%CI 1.92‒12.42) were independent risk factors for blood loss >500 ml (P<0.05). Compared with patients with blood loss ≤500 ml, those with blood loss >500 ml showed remarkably extended activated coagulation time (ACT) (P<0.05). There was a correlation between abnormal r‑TEG and blood loss >500 ml (OR=3.56, 95%CI 1.38‒9.17, P<0.05). Patients with blood loss >500 ml presented increases in the incidences of delayed recovery, pulmonary infection and deep venous thrombosis, and hospitalization cost, compared with those with blood loss ≤500 ml (P<0.05). Conclusions Large tumor volume (with a diameter ≥4 cm), meningioma resection and operation duration >240 min are the risk factors of significant increases in intraoperative blood loss.

Key words: Brain tumor; Blood loss; Predictive risk factors